01-6509. Advisory Committee; Renewals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing the Start Printed Page 15264renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed below for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed below. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).

    DATES:

    Authority for these committees will expire on the date indicated below unless the Commissioner formally determines that renewal is in the public interest.

    Name of committeeDate of expiration
    Anti-Infective Drugs Advisory CommitteeOctober 7, 2002
    Dermatologic and Ophthalmic Drugs Advisory CommitteeOctober 7, 2002
    Biological Response Modifiers Advisory CommitteeOctober 28, 2002
    Technical Electronic Product Radiation Safety Standards CommitteeDecember 24, 2002
    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5496.

    Start Signature

    Dated: March 1, 2001.

    Linda A. Suydam,

    Senior Associate Commissioner.

    End Signature End Further Info End Preamble

    [FR Doc. 01-6509 Filed 3-15-01; 8:45 am]

    BILLING CODE 4160-01-F

Document Information

Published:
03/16/2001
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
01-6509
Dates:
Authority for these committees will expire on the date indicated below unless the Commissioner formally determines that renewal is in the public interest.
Pages:
15263-15264 (2 pages)
PDF File:
01-6509.pdf